Biological optimization for mediastinal lymphoma radiotherapy - a preliminary study.
Conclusions: We developed an individualized, outcome-optimized planning technique for HL. Some of the resulting plans were substantially different from clinical plans. The results varied depending on how risk models were defined or prioritized.
PMID: 32216586 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Rechner LA, Modiri A, Stick LB, Maraldo MV, Aznar MC, Rice SR, Sawant A, Bentzen SM, Vogelius IR, Specht L Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Coronary Heart Disease | Heart | Heart Disease | Hodgkin's Disease | Lymphoma | Study | Toxicology